Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
1.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.1K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.0K
3.0K
Aging01:26

Aging

1.1K
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HTZ-1/H2A.Z expression sustains transcriptional programs that regulate Caenorhabditis elegans lifespan.

Mechanisms of ageing and development·2026
Same author

Multimodal fluorescence-coherence monitoring of polymer curing.

Optics letters·2026
Same author

Factors Influencing Adherence to All-Oral Short-Course Treatment for DR-TB and Establishment of a Predictive Model.

Infection and drug resistance·2026
Same author

BCL-11 enables adaptive stress responses to environmental challenges.

iScience·2026
Same author

Prescribed-rate target tracking for time-delayed systems using output measurements.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Surgical treatment of Emphysematous Osteomyelitis of the spine in malnutrition and anemia patient: a rare case report.

BMC infectious diseases·2026
Same journal

Ablation of the renal tubular gluconeogenic enzyme PCK1 drives AKI-to-CKD transition by negatively regulating the TGF-β/Smad3 signaling pathway.

Cellular and molecular life sciences : CMLS·2026
Same journal

LncRNA modulates Dpp-mediated wing development to influence flight in Aedes aegypti.

Cellular and molecular life sciences : CMLS·2026
Same journal

TROP2 promotes bone metastasis of colorectal cancer through interaction with the fibronectin-integrin axis.

Cellular and molecular life sciences : CMLS·2026
Same journal

PRMT5-Cacna1d axis maintains calcium homeostasis to regulate postnatal motor development in mice.

Cellular and molecular life sciences : CMLS·2026
Same journal

Advances and clinical potential of epigenome editing.

Cellular and molecular life sciences : CMLS·2026
Same journal

Correction to: SIRT3 activation protects from nabumetone-induced mitochondrial toxicity in adult human cardiomyocytes.

Cellular and molecular life sciences : CMLS·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

16.2K

Longevity, aging and rapamycin.

Dan Ehninger, Frauke Neff, Kan Xie

    Cellular and Molecular Life Sciences : CMLS
    |July 13, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Rapamycin, an FDA-approved drug, extends lifespan in mammals by suppressing cancer. It also shows symptomatic benefits for aging traits like cognitive decline, suggesting it primarily targets aging mechanisms through cancer prevention.

    More Related Videos

    A Suppressor Screen for the Characterization of Genetic Links Regulating Chronological Lifespan in Saccharomyces cerevisiae
    10:39

    A Suppressor Screen for the Characterization of Genetic Links Regulating Chronological Lifespan in Saccharomyces cerevisiae

    Published on: September 17, 2020

    6.1K
    Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
    06:56

    Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

    Published on: September 6, 2024

    855

    Related Experiment Videos

    Last Updated: Apr 27, 2026

    A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
    05:28

    A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

    Published on: August 27, 2019

    16.2K
    A Suppressor Screen for the Characterization of Genetic Links Regulating Chronological Lifespan in Saccharomyces cerevisiae
    10:39

    A Suppressor Screen for the Characterization of Genetic Links Regulating Chronological Lifespan in Saccharomyces cerevisiae

    Published on: September 17, 2020

    6.1K
    Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
    06:56

    Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

    Published on: September 6, 2024

    855

    Area of Science:

    • Gerontology
    • Pharmacology
    • Molecular Biology

    Background:

    • Rapamycin is an FDA-approved compound that extends lifespan in mammals.
    • A key question is whether rapamycin slows aging or primarily extends longevity by inhibiting cancer, a major cause of death in mice.

    Purpose of the Study:

    • To review the effects of pharmacological or genetic mammalian target of rapamycin (mTOR) inhibition on aging and longevity in mammals.
    • To evaluate current evidence regarding rapamycin's mechanism of lifespan extension.

    Main Methods:

    • Literature review of studies on rapamycin and mTOR inhibition in mammals.
    • Analysis of evidence linking rapamycin's effects to aging processes and cancer suppression.

    Main Results:

    • Current evidence suggests rapamycin extends lifespan mainly by suppressing cancers.
    • Rapamycin also demonstrates symptomatic effects on aging traits, including age-related cognitive impairments.

    Conclusions:

    • Rapamycin's primary mechanism for lifespan extension in mammals appears to be cancer suppression.
    • The drug also offers symptomatic benefits for certain aging-related conditions.